Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.

G, Reis; Santos Moreira-Silva EA, Dos; DCM, Silva; L, Thabane; AC, Milagres; TS, Ferreira; Santos CVQ, Dos; Souza Campos VH, de; AMR, Nogueira; Almeida APFG, de; ED, Callegari; Figueiredo Neto AD, de; LCM, Savassi; MIC, Simplicio; LB, Ribeiro; R, Oliveira; O, Harari; JI, Forrest; H, Ruton; S, Sprague; P, McKay; AV, Glushchenko; CR, Rayner; EJ, Lenze; AM, Reiersen; GH, Guyatt; EJ, Mills

doi:10.1016/s2214-109x(21)00448-4

Public

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.

Shared by NobleBlocks on Oct 28, 2021 • 12:00 AM UTC

Authors:

Reis G

Dos Santos Moreira-Silva EA

Silva DCM

Abstract

<h4>Background</h4>Recent evidence indicates a potential therapeutic role of fluvoxamine for COVID-19. In the TOGETHER trial for acutely symptomatic patients with COVID-19, we aimed to assess the efficacy of fluvoxamine versus placebo in preventing hospitalisation defined as either retention in a CO...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!